| Digg It |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Marketing Direct > Boost Your Direct Mail Marketing Response Rates with Unilateral Offers, Says Direct Response Agency |
|
Digg It - Boost Your Direct Mail Marketing Response Rates with Unilateral Offers, Says Direct Response Agency
Direct mail marketing rules are made to be broken, or
so I’m told. So break this one and see what
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product happens. Direct mail pundits, me included, recommend that all your direct mail pieces have ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in an offer. The offer, as
you know, is the incentive that you give prospects
to encourage them to re lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. pond. Offers are usually bilateral. You promise to do something if the prospect does somet here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe hing. “Buy two
blouses and we’ll pay the shipping,” for example.
Or “book your appointment before d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro 6 November and
we’ll send you a free Sample Seed Kit.” If the
prospect does nothing, you do nothin ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc g. Both of you
must act if the offer is to work. Offers are
bilateral. Break this rule by easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi making unilateral offers once in a
while. Instead of asking the prospect to do
something, you do nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically omething instead. That’s what a
car dealer in Australia did a while back. He mailed a
letter to hi and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ s customers and enclosed a crisp $50
note. “Your trade-in vehicle sold much quicker than
expected, ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi so we saved ourselves a little money,”
explained the letter. The customer didn’t have to do
anythi ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ng to get the $50 The offer was
unconditional, or unilateral. You can see the value in offe dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod rs that ask for nothing
in return. In this case, which car dealer do you
suppose customers visited cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin the next time they were in
the market for a vehicle? I received a unilateral offer from Chr tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen istopher Knight,
founder and publisher of ezinearticles.com.
Unannounced, he mailed me a huge coff t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel e mug and a
wee note thanking me for being an Expert Author. He
didn’t offer me the mug in exchang ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust e for anything.
I didn’t have to mail in a coupon or take a survey or visit a website or y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products refer my grandmother. Christopher
simply made me a unilateral offer. And yet I
responded by phoni . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de g him during a busy day to thank
him for his kind gesture. Plus, I continued using his
services. S elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip o his unilateral offer did generate a
response from me after all. Funny how that works,
eh? tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:6 Great School Friendly Ideas for Your Restaurant Marketing
|